In these malignancies as in others, an important participation of the BCL-xL protein has been reported, since in lymphoma it has been reported that 80% of these have an overexpression of the protein [2], similar to what has been observed in leukemia [3]. This evidence concerns the gene BCL2L1 and lymphoma.